Titan Pharmaceuticals, Inc. Share Price Nasdaq
Equities
US8883143096
Pharmaceuticals
Sales 2022 | 557K 44.02M | Sales 2023 | 184K 14.54M | Capitalization | 6.21M 491M |
---|---|---|---|---|---|
Net income 2022 | -10M -790M | Net income 2023 | -5M -395M | EV / Sales 2022 | 15.6 x |
Net cash position 2022 | 2.75M 217M | Net cash position 2023 | 6.2M 490M | EV / Sales 2023 | 0.11 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.53% |
Members of the board | Title | Age | Since |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 14/08/22 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 11/10/23 |
Brynner Chiam
BRD | Director/Board Member | - | 11/10/23 |
1st Jan change | Capi. | |
---|---|---|
+35.01% | 709B | |
+29.48% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.49% | 239B | |
+9.12% | 211B | |
-3.68% | 203B | |
+10.77% | 171B |